Ana Luiza Resca, Account Executive and Medical Liaison at Fleury Genomics, shared a post on LinkedIn:
“Representing Fleury Genomics at the 15th International Multidisciplinary Symposium on Breast Cancer (IMSBC) was an excellent opportunity to exchange experiences and closely follow the main updates in the diagnosis and management of breast cancer.
I bring as a highlight the excellent class given by Dr. Leandro Jonata Carvalho Oliveira on gene expression signatures in tumors.
The platforms currently available demonstrate an impact not only on the quality of life of patients, but also on the more efficient use of supplementary health resources.”
Other articles about Breast Cancer on OncoDaily.